Related Experiment Video
Updated: Jun 1, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Potential barriers to adherence in pediatric dermatology
Rachel M Ellis1, Laine H Koch, Erin McGuire
1Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia, USA. ellisrm@evms.edu
Pediatric Dermatology
|May 28, 2011
Summary
Caregivers find medication cost and safety concerning for children with chronic inflammatory skin diseases like atopic dermatitis. Understanding the long-term nature of these skin conditions is also a challenge.
Area of Science:
- Pediatric Dermatology
- Dermatology
- Chronic Inflammatory Skin Diseases
Background:
- Chronic inflammatory skin diseases significantly impact children's quality of life.
- Atopic dermatitis, psoriasis, and acne vulgaris are common conditions requiring long-term management.
- Identifying treatment barriers is crucial for improving patient adherence and outcomes.
Purpose of the Study:
- To identify barriers to treatment adherence in pediatric patients with chronic inflammatory skin diseases.
- To assess caregiver perspectives on treatment complexity, time, cost, formulation, safety, and understanding of chronicity.
- To inform strategies for better management of pediatric skin conditions.
Main Methods:
- A cross-sectional study involving 101 pediatric patients with chronic inflammatory skin diseases.
- Caregivers completed an 11-item Likert scale questionnaire.
- The survey assessed perceptions of treatment complexity, time, medication cost, vehicle formulation, safety, and understanding of disease chronicity.
Main Results:
- Caregivers reported adequate instructions but felt less confident during severe disease flares.
- Treatment complexity, time, and vehicle type were not major barriers.
- Significant concerns were raised regarding medication cost and perceived safety.
- Caregivers demonstrated a limited understanding of the chronic nature of these skin disorders.
Conclusions:
- Medication cost and safety are key concerns for caregivers managing pediatric chronic inflammatory skin diseases.
- Improving caregiver understanding of disease chronicity is essential for effective long-term management.
- Addressing financial and safety concerns may enhance treatment adherence in pediatric dermatology.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:21Barriers to Effective Communication II
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...